Search Results 81-90 of 11807 for Inulin (Prebiotic)

  1. A Study Of Eluxadoline In Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D) Who Have Evidence Of Bile Acid Malabsorption (BAM) - Mayo Clinic

    This study is being done to evaluate the safety and effects of Food and Drug Administration (FDA) approved medication, Eluxadoline, on bowel function in study ...

  2. Videos - Biliary Regenerative Medicine: Robert C. Huebert - Mayo Clinic Research

    Robert C. Huebert, M.D., and Jorge Rakela, M.D., of Mayo Clinic discuss the regenerative properties of the liver to help those with chronic liver disease.

  3. Doctors and departments - Mayo Clinic

    Mayo Clinic has made important contributions to the treatment of IBD over the years, including pioneering ileoanal anastomosis (J-pouch surgery) and ...

  4. John M. Wilkinson, M.D. - Mayo Clinic Faculty Profiles

    Improved systems for integrated behavioral health. Dr. Wilkinson is one of the local champions and research collaborators studying the statewide Depression ...

  5. Bariatric Surgery Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the associated effects of probiotic supplements on weight loss, visceral and total body fat, and changes in the ...

  6. Gastroenterology and Hepatology - Clinical trials

    The study aims are to develop a consent-based IRB proposal that will enroll newborns who have imperforate anus. The proposal will include permission for ...

  7. AMG 181 in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

    After completing all screening assessments and meeting all eligibility criteria, subjects will be randomized to receive placebo or AMG 181 at various doses per ...

  8. Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

  9. Water: How much should you drink every day? - Mayo Clinic

    Know how much water to drink to stay healthy and hydrated.

  10. A Study Of The Efficacy And Safety Of Upadacitinib (ABT-494) In Subjects With Moderately To Severely Active Crohn's Disease Who Have Inadequately Responded To Or Are Intolerant To Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in participants with moderately and ...